These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

538 related items for PubMed ID: 17608581

  • 1. Tissue plasminogen activator and plasminogen activator inhibitor-1 gene polymorphisms in patients with chronic periodontitis.
    Gürkan A, Emingil G, Saygan BH, Cinarcik S, Atilla G, Köse T, Berdeli A.
    J Periodontol; 2007 Jul; 78(7):1256-63. PubMed ID: 17608581
    [Abstract] [Full Text] [Related]

  • 2. Gene polymorphisms of tissue plasminogen activator and plasminogen activator inhibitor-1 in Turkish patients with generalized aggressive periodontitis.
    Emingil G, Berdeli A, Gürkan A, Han Saygan B, Köse T, Atilla G.
    J Clin Periodontol; 2007 Apr; 34(4):278-84. PubMed ID: 17257155
    [Abstract] [Full Text] [Related]

  • 3. Tissue plasminogen activator and plasminogen activator inhibitor type 1 gene polymorphism in patients with gastric ulcer complicated with bleeding.
    Kim HS, Hwang KY, Chung IK, Park SH, Lee MH, Kim SJ, Hong SY.
    J Korean Med Sci; 2003 Feb; 18(1):58-64. PubMed ID: 12589088
    [Abstract] [Full Text] [Related]

  • 4. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.
    Sartori MT, Wiman B, Vettore S, Dazzi F, Girolami A, Patrassi GM.
    Thromb Haemost; 1998 Dec; 80(6):956-60. PubMed ID: 9869167
    [Abstract] [Full Text] [Related]

  • 5. Association of tissue plasminogen activator and plasminogen activator inhibitor polymorphism with myocardial infarction: a meta-analysis.
    Gong LL, Peng JH, Han FF, Zhu J, Fang LH, Wang YH, Du GH, Wang HY, Liu LH.
    Thromb Res; 2012 Sep; 130(3):e43-51. PubMed ID: 22771216
    [Abstract] [Full Text] [Related]

  • 6. Plasminogen-activator-inhibitor-1 promoter polymorphism as a risk factor for adult periodontitis in non-smokers.
    Izakovicová Hollá L, Bucková D, Fassmann A, Benes P, Znojil V.
    Genes Immun; 2002 Aug; 3(5):292-4. PubMed ID: 12140748
    [Abstract] [Full Text] [Related]

  • 7. [The influence of I/D polymorphism of the angiotensin I converting enzyme (ACE) gene and 4G/5G polymorphism of plasminogen activator inhibitor (PAI-1) gene promoter on the haemostatic system in patients with essential hypertension and dyslipidemia].
    Nowakowska A.
    Ann Acad Med Stetin; 2005 Aug; 51(1):95-105. PubMed ID: 16496609
    [Abstract] [Full Text] [Related]

  • 8. 4G/5G polymorphism of PAI-1 gene and Alu-repeat I/D polymorphism of TPA gene in Turkish patients with polycystic ovary syndrome.
    Karadeniz M, Erdogan M, Berdeli A, Saygili F, Yilmaz C.
    J Assist Reprod Genet; 2007 Sep; 24(9):412-8. PubMed ID: 17661167
    [Abstract] [Full Text] [Related]

  • 9. Plasminogen activator inhibitor -1 gene 4G/5G polymorphism in patients with breast cancer.
    Eroglu A, Ulu A, Cam R, Akar N.
    J BUON; 2006 Sep; 11(4):481-4. PubMed ID: 17309181
    [Abstract] [Full Text] [Related]

  • 10. Plasminogen activator inhibitor-1 (PAI-1) gene 4G/5G promoter polymorphism is not associated with breast cancer.
    Błasiak J, Smolarz B.
    Acta Biochim Pol; 2000 Sep; 47(1):191-9. PubMed ID: 10961693
    [Abstract] [Full Text] [Related]

  • 11. Role of the tissue-type plasminogen activator -7351C > T and plasminogen activator inhibitor 1 4G/5G gene polymorphisms in central serous chorioretinopathy.
    Malle EM, Posch-Pertl L, Renner W, Pinter-Hausberger S, Singer C, Haas A, Wedrich A, Weger M.
    Ophthalmic Genet; 2018 Dec; 39(6):714-716. PubMed ID: 30442055
    [Abstract] [Full Text] [Related]

  • 12. Plasminogen activator inhibitor 1 (PAI-1) levels and gene promoter polymorphisms in subjects with colorectal cancer.
    Smolarz B, Blasiak J, Kulig A, Romanowicz-Makowska H, Dziki A, Ulanska J, Pander B, Szewczyk T.
    J Exp Clin Cancer Res; 2001 Jun; 20(2):247-52. PubMed ID: 11484982
    [Abstract] [Full Text] [Related]

  • 13. The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism.
    Stegnar M, Uhrin P, Peternel P, Mavri A, Salobir-Pajnic B, Stare J, Binder BR.
    Thromb Haemost; 1998 May; 79(5):975-9. PubMed ID: 9609232
    [Abstract] [Full Text] [Related]

  • 14. Association of the 4G/5G polymorphism in the promoter region of plasminogen activator inhibitor-1 with abdominal aortic aneurysms.
    Rossaak JI, Van Rij AM, Jones GT, Harris EL.
    J Vasc Surg; 2000 May; 31(5):1026-32. PubMed ID: 10805895
    [Abstract] [Full Text] [Related]

  • 15. Relationship between gene polymorphism of the PAI-1 promoter and myocardial infarction.
    Fu L, Jin H, Song K, Zhang C, Shen J, Huang Y.
    Chin Med J (Engl); 2001 Mar; 114(3):266-9. PubMed ID: 11780311
    [Abstract] [Full Text] [Related]

  • 16. Genotype frequency of plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism in healthy Japanese males and its relation to PAI-1 levels.
    Matsubara Y, Murata M, Isshiki I, Watanabe R, Zama T, Watanabe G, Watanabe K, Ikeda Y.
    Int J Hematol; 1999 Jan; 69(1):43-7. PubMed ID: 10641442
    [Abstract] [Full Text] [Related]

  • 17. [The role of 4G/5G polymorphism in the regulation of plasma levels of PAI-1: a model of interaction between genetic and environmental factors].
    Burzotta F, Di Castelnuovo A, Amore C, D'Orazio A, Donati MB, Iacoviello L.
    Cardiologia; 1998 Jan; 43(1):83-8. PubMed ID: 9534297
    [Abstract] [Full Text] [Related]

  • 18. [Relationship between polymorphisms of plasminogen activator inhibitor-1 promoter gene and pulmonary thromboembolism in Chinese Han population].
    Zhai ZG, Wang C, Yang YH, Pang BS, Xiao B, Liu YM, Mao YL, Weng XZ.
    Zhonghua Yi Xue Za Zhi; 2006 May 23; 86(19):1313-7. PubMed ID: 16796899
    [Abstract] [Full Text] [Related]

  • 19. Plasminogen activator inhibitor-1 4G/5G polymorphism in breast cancer patients and its association with tissue PAI-1 levels and tumor severity.
    Castelló R, España F, Vázquez C, Fuster C, Almenar SM, Aznar J, Estellés A.
    Thromb Res; 2006 May 23; 117(5):487-92. PubMed ID: 15907980
    [Abstract] [Full Text] [Related]

  • 20. A study of the possible association of plasminogen activator inhibitor type 1 4G/5G insertion/deletion polymorphism with susceptibility to schizophrenia and in its subtypes.
    Yenilmez C, Ozdemir Koroglu Z, Kurt H, Yanas M, Colak E, Degirmenci I, Gunes HV.
    J Clin Pharm Ther; 2017 Feb 23; 42(1):103-107. PubMed ID: 27796029
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.